Researchers create cancer diagnostic test for early detection
Johns Hopkins oncologist Dr. David Sidransky leads a study showing a test that detects cancer by matching clonal DNA markers across tissue and body fluids. The method aims to find cancers earlier than X-rays or direct exams, with potential use for bladder and cervical cancer within a year and broader applicability later, pending large trials.
MENTIONED IN THIS ARTICLE
Proceedings
National Academy of Science
David Sidransky
Johns Hopkins Oncology Center
New York Times
Sidransky
Experimental MS drugs show promise in relapsing form
New experimental drugs reduced attack frequency in relapsing multiple sclerosis, with one possibly delaying long term disability. The study involved 75,000 to 140,000 Americans with relapsing MS, a group also making up 250,000 to 350,000 nationally. Interferon beta B Betaseron remains a treatment option. Stephen Reingold from the National MS Society welcomed potential new choices.
MENTIONED IN THIS ARTICLE
EW York
Food and Drug Administration
Stephen Reingold
National
Multiple Sclerosis Society
Also Mentioned on This Page
Jerry Harper Law Offices
Mass
Lawrence
J.D
Dccca Center
17Th Street
Ottawa
The
Kansas Health Foundation
Ah BL Creations, Inc
West Main Gardner
Cricket Lane
Clifton
Jantzen
Isle of Cotton
Lavon
Spencer Douglas
Sherwood
Calcraft
Carhartt
Haggar
EAE
Jeans Jr
Missy
Judy Bond
Laura Mae
Gopher
Bauman
Lane
Topper
Phoenix
Garret A
Garnett
Beltone Hearing Aid Center
Rillone
Feckham’s
Vermont
Kolorkraft
Ince
Kramer Drug Store